TruScreen Group Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

TruScreen Group şirketinin toplam hissedar öz sermayesi NZ$3.2M ve toplam borcu NZ$0.0 olup, bu da borç-öz sermaye oranını 0% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla NZ$4.0M ve NZ$798.4K dir.

Anahtar bilgiler

Borç/özkaynak oranı

NZ$0

Borç

Faiz karşılama oranı	n/a
Nakit	NZ$2.73m
Eşitlik	NZ$3.23m
Toplam yükümlülükler	NZ$798.45k
Toplam varlıklar	NZ$4.03m

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: TRU 'nin kısa vadeli varlıkları ( NZ$4.0M ) kısa vadeli yükümlülüklerini ( NZ$769.4K ) aşıyor.

Uzun Vadeli Yükümlülükler: TRU şirketinin kısa vadeli varlıkları ( NZ$4.0M ) uzun vadeli yükümlülüklerini ( NZ$29.1K ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: TRU borçsuzdur.

Borcun Azaltılması: TRU şirketinin 5 yıl önce borç/öz sermaye oranı 5.5% iken borcu yok.

Bilanço

Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: TRU şirketinin mevcut serbest nakit akışına göre bir yıldan fazla yetecek nakit pisti bulunmaktadır.

Tahmini Nakit Akışı: TRU serbest nakit akışı her yıl % { 8.2 1.2 |round(1)}} yıl boyunca yeterli nakit akışına sahip olacaktır.

TruScreen Group Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

TruScreen Group Limited, Annual General Meeting, Sep 03, 2024

Insufficient new directors

Truscreen Pty Limited Announces Change of its Sydney, NSW Operations Address

Full year 2024 earnings released: NZ$0.005 loss per share (vs NZ$0.007 loss in FY 2023)

New major risk - Share price stability

Full year 2024 earnings released: NZ$0.005 loss per share (vs NZ$0.007 loss in FY 2023)

New minor risk - Financial data availability

New minor risk - Share price stability

Insufficient new directors

New minor risk - Shareholder dilution

TruScreen Group Limited has filed a Follow-on Equity Offering in the amount of AUD 0.5 million.

TruScreen Group Limited Announces CEO Changes

TruScreen Group Limited has filed a Follow-on Equity Offering in the amount of AUD 2.618158 million.

TruScreen Group Limited, Annual General Meeting, Aug 29, 2023

New major risk - Share price stability

Full year 2023 earnings released: NZ$0.66 loss per share (vs NZ$0.022 loss in FY 2022)

First half 2023 earnings released: NZ$0.003 loss per share (vs NZ$0.003 loss in 1H 2022)

TruScreen Group Limited Appoints Beata Edling as Chief Executive Officer

TruScreen Group Limited, Annual General Meeting, Sep 06, 2022

Full year 2022 earnings released: NZ$0.022 loss per share (vs NZ$0.011 loss in FY 2021)

Full year 2022 earnings released: NZ$0.022 loss per share (vs NZ$0.011 loss in FY 2021)

TruScreen Group Limited to Report Fiscal Year 2022 Results on May 30, 2022

TruScreen Group Limited Releases China-Based Cervical Cancer Screening Trial

First half 2022 earnings: EPS in line with expectations, revenues disappoint

First half 2022 earnings: EPS in line with expectations, revenues disappoint

Full year 2021 earnings released: NZ$0.011 loss per share (vs NZ$0.023 loss in FY 2020)

Full year 2021 earnings released: NZ$0.011 loss per share (vs NZ$0.023 loss in FY 2020)

Forecast to breakeven in 2024

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Nakit Pist Analizi

Sağlıklı şirketleri keşfedin

TruScreen Group Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

TruScreen Group Limited, Annual General Meeting, Sep 03, 2024

Insufficient new directors

Truscreen Pty Limited Announces­ Change of its Sydney, NSW Operations Address

Full year 2024 earnings released: NZ$0.005 loss per share (vs NZ$0.007 loss in FY 2023)

New major risk - Share price stability

Full year 2024 earnings released: NZ$0.005 loss per share (vs NZ$0.007 loss in FY 2023)

New minor risk - Financial data availability

New minor risk - Share price stability

Insufficient new directors

New minor risk - Shareholder dilution

TruScreen Group Limited has filed a Follow-on Equity Offering in the amount of AUD 0.5 million.

TruScreen Group Limited Announces CEO Changes

TruScreen Group Limited has filed a Follow-on Equity Offering in the amount of AUD 2.618158 million.

TruScreen Group Limited, Annual General Meeting, Aug 29, 2023

New major risk - Share price stability

Full year 2023 earnings released: NZ$0.66 loss per share (vs NZ$0.022 loss in FY 2022)

First half 2023 earnings released: NZ$0.003 loss per share (vs NZ$0.003 loss in 1H 2022)

TruScreen Group Limited Appoints Beata Edling as Chief Executive Officer

TruScreen Group Limited, Annual General Meeting, Sep 06, 2022

Full year 2022 earnings released: NZ$0.022 loss per share (vs NZ$0.011 loss in FY 2021)

Full year 2022 earnings released: NZ$0.022 loss per share (vs NZ$0.011 loss in FY 2021)

TruScreen Group Limited to Report Fiscal Year 2022 Results on May 30, 2022

TruScreen Group Limited Releases China-Based Cervical Cancer Screening Trial

First half 2022 earnings: EPS in line with expectations, revenues disappoint

First half 2022 earnings: EPS in line with expectations, revenues disappoint

Full year 2021 earnings released: NZ$0.011 loss per share (vs NZ$0.023 loss in FY 2020)

Full year 2021 earnings released: NZ$0.011 loss per share (vs NZ$0.023 loss in FY 2020)

Forecast to breakeven in 2024

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Nakit Pist Analizi

Sağlıklı şirketleri keşfedin

Truscreen Pty Limited Announces Change of its Sydney, NSW Operations Address